Biomedical Technology Firm Kangpu Biomedical Technology Raised Nearly ¥100 Million in a Series Pre-B Round Funding Led by Guozhong Venture Capital Management and Furong Investment

Biomedical Technology Firm Kangpu Biomedical Technology Raised Nearly ¥100 Million in a Series Pre-B Round Funding Led by Guozhong Venture Capital Management and Furong Investment
Biomedical Technology Firm Kangpu Biomedical Technology Raised Nearly ¥100 Million in a Series Pre-B Round Funding Led by Guozhong Venture Capital Management and Furong Investment

 

Biomedical technology firm Kangpu biomedical technology raised nearly ¥100 million in a Series Pre-B round funding led by Guozhong Venture Capital Management and Furong Investment and followed by its previous shareholder Northern Light Venture Capital. The investment will be used to accelerate clinical trail on its projects.

Established in 2012, Kangpu Biomedical Technology is an innovative bio-medicine company focusing on clinical trail. Its main research areas re cancer, autoimmune diseases and inflammation.

 

South Africa Today


Read more at VolaNews